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Detection of self nucleic acids by Toll-like receptors
(TLR) preciptates autoimmune diseases, including
systemic lupus erythematosus (SLE). It remains
unknown how TLR signals in specific cell types
contribute to distinct manifestations of SLE. Here,
we demonstrate that formation of anti-nuclear anti-
bodies in MRL.Faslpr mice entirely depends on the
TLR signaling adaptor MyD88 in B cells. Further,
MyD88 deficiency in B cells ameliorated nephritis,
including antibody-independent interstitial T cell
infiltrates, suggesting that nucleic acid-specific B
cells activate nephrotoxic T cells. Surprisingly,
MyD88 deletion in dendritic cells (DCs) did not affect
nephritis, despite the importance of DCs in renal
inflammation. In contrast, MyD88 in DCs was critical
for dermatitis, revealing a separate pathogenetic
mechanism. DC-expressed MyD88 promoted inter-
feron-a production by plasmacytoid DCs, which
was associated with Death domain-associated
protein 6 upregulation and B lymphopenia. Our
findings thus reveal unique immunopathological
consequences of MyD88 signaling in B cells and
DCs in lupus.
INTRODUCTION
Activation of the immune system by aberrant self nucleic acid
detection has emerged as a fundamental mechanism in the
pathogenesis of various autoimmune diseases, in particular
systemic lupus erythematosus (SLE). In murine models of SLE,
self nucleic acids stimulate Toll-like receptor 7 (TLR7) and
TLR9, endosomal receptors that normally protect from infection
by detecting foreign nucleic acids (Christensen et al., 2006). Both
TLR7 and TLR9 signal via the adaptor MyD88. Deficiency for
MyD88 abrogatesmost attributes of lupus in several lupus-prone
mouse strains including MRL.Faslpr mice with polygenic suscep-
tibility (Nickerson et al., 2010). Myd88/ MRL.Faslpr mice have528 Immunity 38, 528–540, March 21, 2013 ª2013 Elsevier Inc.minimal organ disease and lack autoantibody specificities that
are dependent on TLR7 (anti-RNA, anti-Sm) as well as TLR9
(anti-dsDNA, anti-nucleosome). MRL.Faslpr mice doubly defi-
cient for TLR7 and TLR9 largely mirror theMyd88/MRL.Faslpr
phenotype (Nickerson et al., 2010). The similarity in phenotypes
of these twomutant strains indicates that combined disruption of
TLR7 and TLR9 signaling accounts for the loss of characteristic
lupus features in Myd88/ MRL.Faslpr mice, whereas interfer-
ence with other MyD88-dependent pathways, such as IL-1 and
IL-18 receptor signaling, does not essentially contribute to the
Myd88/ MRL.Faslpr phenotype.
These studies of global gene deficiency in lupus-prone mice
leave several fundamental questions unanswered. First,
although B cells, DCs, and other myeloid cells express TLR7
and TLR9, it is uncertain which of these cell types are directly
activated by nucleic acid-sensing TLRs in lupus and what the
requirements for this activation are. In lupus, B cells and DCs
become spontaneously activated and can promote disease by
several mechanisms. B cells and conventional DCs (cDCs) are
major antigen (Ag)-presenting cells that regulate T cell-mediated
autoimmunity (Chan and Shlomchik, 1998; Teichmann et al.,
2010). B cells further contribute to lupus pathogenesis by auto-
antibody secretion. Plasmacytoid DCs (pDCs) probably drive
disease by type I interferon (IFN-I) production (Ro¨nnblom et al.,
2011).
In vitro experiments suggest that lupus autoantigens can
indeed directly activate B cells and DCs via nucleic acid-specific
TLRs. In B cells, targeting of mammalian DNA, RNA, or immune
complexes (ICs) that contain nucleic acids by the B cell receptor
to endosomal TLRs leads to robust proliferation (Marshak-
Rothstein, 2006). In DCs, uptake of ICs and delivery to endo-
somes mediated by FcgRs induces cytokine secretion (Lo¨vgren
et al., 2006). Of note, if DCs require nucleic acids to be com-
plexed with autoantibodies for effective shuttling to endosomal
TLRs, then TLR-mediated DC activation would depend on prior
B cell activation. However, entry of nucleic acids to endosomes
in DCs might also be facilitated by high-mobility group box 1
protein (HMGB1) (Tian et al., 2007) and the antimicrobial peptide
LL37 (Lande et al., 2007).
Second, assuming that B cells and DCs are directly activated
by endogenous TLR ligands in lupus, it is not clear whether direct
TLR-driven activation is an indispensable requirement for these
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modes of activation could compensate for a loss of TLR stimula-
tion. B cells, for example, can effectively be activated by
synergistic engagement of the B cell receptor and CD40 (Bishop
and Hostager, 2003), leading to class switch recombination and
antibody-forming cell (AFC) differentiation. In immunization
studies, cDCs required direct activation by pattern recognition
receptors, such as TLRs, to induce T cell differentiation (Joffre
et al., 2009). Yet in systemic autoimmunity this prerequisite
might be weakened and cDCs might have disease-relevant
functions that extend beyond T cell priming. Further, whether
TLR activation is necessary for pDCs to secrete IFN-I in lupus
has not been established.
Finally, the functional consequences of TLR-mediated
activation of distinct cell types by self nucleic acids for lupus
development are unknown. Human SLE and murine lupus
both display diverse clinical manifestations such as autoanti-
body formation, excessive production of IFN-I and interferon g
(IFN-g), hematological changes, organ infiltration, lymphade-
nopathy, and splenomegaly. It is important to understand which
aspects of disease pathogenesis specifically require B cells,
DCs, or both cell types to be directly activated by nucleic acid-
sensing TLRs.
Dissecting how TLR signals in two major types of Ag-present-
ing cells regulate lupus requires the application of genetic tools
for tissue-specific gene inactivation to a murine polygenic model
of lupus. We combined two approaches—Cre-loxP recombina-
tion and mixed bone marrow chimeras—to inactivate Myd88,
and hence TLR7 and TLR9 signaling, selectively in B cells or
DCs in lupus-prone MRL.Faslpr mice. This strategy allowed us
to define the specific contributions of B cell- and DC-intrinsic
MyD88 signaling to self-reactive B and T cell stimulation and
how MyD88 signals in B cells and DCs cooperate with and
complement each other in establishing the full clinical picture
of lupus.
RESULTS
Selective Deletion ofMyd88 in DCs and B Cells
To study the role of MyD88 in DCs and B cells in lupus, we gener-
ated CD11c-Cre (Caton et al., 2007) and CD19-Cre (Rickert
et al., 1997) Myd88fl/fl MRL.Faslpr mice (called DC-Myd88D and
B-Myd88D mice, respectively, hereafter). In DC-Myd88D mice,
deletion of the Myd88fl allele, as measured by quantitative real-
time (qRT) PCR on genomic DNA, was 95% in cDCs (Table S1
available online)—virtually complete given a sorting purity
of97% for cDCs—and 78% in pDCs. Because CD11c expres-
sion is not restricted to DCs, we also determined Myd88fl dele-
tion in lymphoid cells, which was limited (<25%, Table S1). Of
note, we have previously shown that in CD11c-Cre MRL.Faslpr
mice, Cre is not substantially expressed in marginal zone or met-
allophilic macrophages (Teichmann et al., 2010). In B-Myd88D
mice, we assessed deletion efficacy by qRT-PCR and by
in vitro CFSE proliferation assay by using sorted splenic B cells
(Table S1). Both assays showed that CD19-Cre-mediated dele-
tion of the Myd88fl allele was quite effective in B cells. Around
90% of Myd88fl alleles were deleted as measured by qRT-PCR
and 87% of B cells did not divide in response to TLR9 stimula-
tion. However, we reasoned that if there were selective pressurein favor of MyD88-sufficient self-reactive B cells to produce
AFCs in lupus-prone B-Myd88D mice, the extensive self-
antigen-driven clonal expansion of residual MyD88-responsive
B cells (10%) could permit such cells to generate a substantial
anti-self humoral immune response. In support of this notion,
we found that in contrast to 90% deletion of the Myd88fl allele
in B cells, deletion by qRT-PCR in splenic AFCs was only 48%
(Table S1), revealing that MyD88-sufficient B cells did have an
advantage over their MyD88-deficient counterparts to become
AFCs. Thus, the utility of the CD19-Cre MyD88fl/fl approach to
evaluate the dependence of lupus phenotypes on MyD88 in
B cells is limited to instances in which partial MyD88 deficiency
in B cells does impair an aspect of disease.
In view of this limitation, to generate lupus-prone mice with
complete deletion of Myd88 in B cells, we lethally irradiated B
cell-deficient Jh MRL.Faslpr mice and reconstituted them with
a mixture of BM from Jh MRL.Faslpr (80%) and Myd88/
MRL.Faslpr (20%) mice. In such chimeras (called B-Myd88/
mice hereafter), all B cells originate from Myd88/ stem cells
whereas other BM-derived cell types are mostly (80%) of wild-
type phenotype (Table S1). Irradiated lupus-prone mice develop
a robust spontaneous anti-self B and T cell immune response
but a caveat is that end-organ disease remains mild. Thus,
except for data on organ manifestations, we present results
from B-Myd88/ chimeric mice in the main figures and results
from B-Myd88D mice in supplemental figures.
B Cell-Intrinsic MyD88 Signaling Is Absolutely Required
for ANA and Essential for Rheumatoid Factor Formation
In murine vaccination models, the magnitude of the IgG
response against the antigen is controlled by MyD88 in B cells
or DCs depending on the type of the Ag (Hou et al., 2011). We
asked whether MyD88 in B cells or DCs regulates the anti-self
humoral immune response in lupus. Total serum IgG was
decreased by 47% in B-Myd88/ mice (Figure 1A) (35% in
B-Myd88D mice; Figure S1A), whereas deletion of Myd88 in
DCs did not affect the serum IgG concentration (Figure 1B).
However, the isotype subclass distribution of IgG was altered
in DC-Myd88D mice, with an increase in IgG1 and a reduction
in IgG2a. IgG anti-nuclear antibodies (ANAs) were completely
absent in B-Myd88/ mice whereas sera from littermate
controls invariably produced homogenous staining patterns,
indicating the presence of anti-DNA and anti-chromatin anti-
bodies (Figure 1C). All sera from DC-Myd88D mice contained
IgG ANAs (data not shown). The distribution of dominant ANA
staining patterns was similar in DC-Myd88D and control mice
(Figure 1D). This suggested that ablation of Myd88 in DCs
does not lead to a major loss or gross alteration in the composi-
tion of autoantibodies. Similar to the total IgG isotype subclass
distribution, there was a relative increase of IgG1 compared to
IgG2a ANAs in DC-Myd88D mice (Figure 1E).
To quantitate serum autoantibodies, we measured anti-
nucleosome IgG, IgG1, and IgG2a by ELISA. As expected,
anti-nucleosome IgG was virtually absent in B-Myd88/ mice
and 83% reduced in B-Myd88D mice (Figures 1F and S1B). In
DC-Myd88D mice, serum anti-nucleosome IgG was 47%
decreased, compared to littermate controls (Figure 1G). The
reduction in anti-nucleosome IgG in DC-Myd88D mice was
mainly a result of less IgG2a anti-nucleosome (Figure 1G).Immunity 38, 528–540, March 21, 2013 ª2013 Elsevier Inc. 529
Figure 1. B Cell-Intrinsic MyD88 Signaling Is Absolutely Required for ANA and Critical for Rheumatoid Factor Formation
(A and B) Serum Ig isotype concentrations of (A) control (n = 12) and B-Myd88/ (n = 12) or of (B) control (n = 34) and DC-Myd88D (n = 22) mice.
(C) Representative Hep-2 ANA staining patterns of a control and a B-Myd88/ mouse via serum dilutions of 1:100. ANAs are routinely detectable at serum
dilutions of 1:16,000 to 1:32,000 in wild-type MRL.Faslpr mice (not shown). Scale bars represent 50 mm.
(D) ANA staining patterns produced by sera from control and DC-Myd88D mice. The number in the circles indicate the number of mice analyzed.
(E) Ratio of mean nuclear fluorescence intensity IgG1 divided by mean nuclear fluorescence intensity IgG2a. n = 11 for control and n = 23 for DC-Myd88D mice.
(F and G) Serum concentrations of anti-nucleosome IgG, IgG1, and IgG2a of (F) control (n = 12) and B-Myd88/ (n = 12) or of (G) control (n = 34) and DC-Myd88D
(n = 22) animals.
(H and I) Number of anti-IgG1 and anti-IgG2a rheumatoid factor-secreting cells per spleen determined by ELISpot assay. n = 6–12 for control and B-Myd88/
mice (H); n = 11–12 for control and n = 16 for DC-Myd88D mice (I).
Bar graphs show mean values with SEM. Scatter plots display data of individual mice and median values. See also Figure S1.
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Functions of MyD88 in B Cells and DCs in LupusThus, MyD88-dependent DC activation does contribute (albeit
weakly) to autoantibody production. To assess the rheumatoid
factor (RF, anti-Fcg autoantibodies) response, we enumerated
RF-secreting cells by ELISpot assay. This approach is prefer-
able to measuring serum concentrations because alterations
in IgG serum concentrations in B-Myd88/ and DC-Myd88D530 Immunity 38, 528–540, March 21, 2013 ª2013 Elsevier Inc.mice could lead to apparent changes in RF concentrations.
Strikingly, spleens of B-Myd88/ mice harbored 98% fewer
anti-IgG1 and 99% fewer anti-IgG2a-forming cells than controls
(Figure 1H). Given the dominant role of TLR7 and TLR9
upstream of MyD88 in lupus-prone mice (Nickerson et al.,
2010), this implies that the RF response is chiefly driven by
Figure 2. The Spontaneous Plasmablast Response Largely Depends on B Cell-Expressed MyD88
(A and B) Number of k light chain AFCs per spleen determined by (A) ELISpot assay and (B) flow cytometry (intracellular-khiCD138+CD19intCD44+TCRb). n = 12
for control and B-Myd88/ mice.
(C) Staining of splenic k light chain AFCs for active caspases to identify apoptotic cells. n = 4 for control and n = 5 for B-Myd88/ mice.
(D and E) As in (A) and (B) but for control (n = 28) and DC-Myd88D (n = 16) mice.
(F) Representative staining profiles of splenic AFCs of control (n = 12) and B-Myd88/ (n = 12) mice. Cells were first gated on CD44+TCRb. Values indicate
percentage of live splenocytes (mean).
(G) ELISpot assays for IgG1, IgG2a, and IgM AFCs in the spleen were performed. Numbers of IgG1 and IgG2a spots were normalized to numbers of IgM spots to
demonstrate the effect of B cell-specific Myd88 deletion on class switch recombination. n = 12 for control and B-Myd88/ mice.
(H) As in (G) but for control (n = 28) and DC-Myd88D (n = 16) mice.
Bar graphs show mean values with SEM. Scatter plots display data of individual mice and median values. See also Figure S2.
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contrast, DC-Myd88D mice had only a 60% reduction in anti-
IgG2a and no significant decrement (p = 0.29) in anti-IgG1-
secreting cells (Figure 1I).
Taken together, ANA formation was entirely dependent and
RF formation largely dependent on B cell-intrinsic MyD88
signaling. DCs activated through MyD88 contributed only
modestly to autoantibody generation, either directly, for example
by secretion of B cell-trophic factors such as BAFF or APRIL
(Rickert et al., 2011), or indirectly, for example by priming of T
helper cells that augment TLR-driven autoreactive plasmablast
responses (Odegard et al., 2008; Sweet et al., 2011).AFC Generation and Class Switch Recombination in the
Spleen Critically Depend on MyD88 in B Cells
Anti-DNA and RF AFCs in MRL.Faslpr mice are mainly located
at extrafollicular sites in the spleen (Shlomchik, 2008). We
determined the number of splenic AFCs by ELISpot and flow
cytometry (intracellular-khiCD138+CD19intCD44+TCRb). Corre-
sponding to the profound impact of B cell-specific Myd88
deletion on serum autoantibody concentrations, spleens from
B-Myd88/ mice contained around 90% fewer k light chain
AFCs (Figures 2A, 2B, and 2F). Most splenic AFCs in MRL.Faslpr
mice are short-lived plasmablasts. Notably, residual AFCs in
B-Myd88/ mice displayed a higher k light chain content andImmunity 38, 528–540, March 21, 2013 ª2013 Elsevier Inc. 531
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suggesting that such cells may represent more fully differenti-
ated plasma cells rather than short-lived plasmablasts. Staining
for active caspases confirmed that residual AFCs in B-Myd88/
mice underwent apoptosis at a lower rate than did their counter-
parts in controls (Figure 2C). In contrast, AFC numbers in B-
Myd88D mice, with only partial deletion of Myd88 in B cells,
were unaffected (Figure S2A), indicative of very strong positive
selection for the few B cells (10%) that did not fully inactivate
Myd88. AFC numbers were also not reduced in DC-Myd88D
mice (Figures 2D and 2E), consistent with the modest contribu-
tion of DC-intrinsic MyD88 signaling to anti-nucleosome IgG
and anti-IgG2a RF generation.
Class switching—measured by the ratios IgG1:IgM and
IgG2a:IgM ELISpots—was markedly impaired in B-Myd88/
mice (Figure 2G). In DC-Myd88Dmice we found a small decrease
in IgG2a and a more pronounced increase in IgG1 AFCs relative
to IgMAFCs (Figure 2H), arguing against a general defect in class
switch recombination. The shift from IgG2a to IgG1 in DC-
Myd88Dmice, which was also observed in IgG serum concentra-
tions, is reminiscent of the phenotype of IFN-g deficiency in
MRL.Faslpr mice (Balomenos et al., 1998). IFN-g is known to
promote isotype switch to IgG2a.
Themechanisms that lead to extrafollicular B cell responses in
MRL.Faslpr and many other lupus-prone mouse strains—
including BXSB/Yaa, NZB/W F1, B6.Sle123, and BAFF Tg—
are poorly understood (Shlomchik, 2008). Evidence for the
involvement of DCs in this process comes from C57BL/6 mice
with DC-specific deficiency for the ubiquitin-editing protein
A20; these mice display a strong extrafollicular plasmablast
response (Kool et al., 2011). We investigated localization of the
B cell response in control and DC-Myd88Dmice by immunofluo-
rescence microscopy. Spontaneous GC formation is minimal in
older MRL.Faslpr mice, but the reasons for this are unknown.
Remarkably, in spleens of DC-Myd88D mice, clusters of PNA+
cells that contain zones with and without follicular dendritic cells,
indicative of GCs, were present (Figures S2B and S2C). In
contrast, GCs were undetectable in control mice (Figure S2B),
as expected. GC-like structures were also undetectable in
B-Myd88/ mice (data not shown), which was unsurprising
given that MyD88 in B cells was essential for spontaneous
B cell activation. These data suggest that persistent activation
of DCs through the TLR-MyD88 pathway interferes with GC
formation, shedding light on themechanisms leading to a paucity
of GCs in these lupus-prone mice.
In summary, the great majority of splenic AFCs in MRL.Faslpr
mice were generated as a result of B cell-intrinsic MyD88
signaling. MyD88 in B cells also promoted class switch recombi-
nationwhereas DC-expressedMyD88 influenced the direction of
isotype switching. ContinuousMyD88 signaling in DCs appeared
to hinder GC formation.
DC- and B Cell-Intrinsic MyD88 Signals Regulate
the Size of the B Cell Compartment
B lymphocytopenia is a common feature of lupus patients with
active disease and is also found in aged MRL.Faslpr mice.
Notably, both, B-Myd88/ and DC-Myd88Dmice had increased
B cell numbers compared to their respective littermate controls
(Figures 3A and 3B). In aged MRL.Faslpr mice, most B cells are532 Immunity 38, 528–540, March 21, 2013 ª2013 Elsevier Inc.located in the marginal zone rather than in follicles. As antici-
pated, immunofluorescence histology of spleens from littermate
controls of B-Myd88/ and DC-Myd88D mice demonstrated
a lack of well-developed B cell follicles (Figures S3A and S3B).
In contrast, B cell follicles were readily detectable in DC-
Myd88D and B-Myd88/ mice (Figures S3A and S3B). Thus,
MyD88-dependent signal transduction in both B cells and DCs
led to reduced overall numbers of B cells along with suppressed
follicular B cell localization.
We sought to further define how MyD88 signals in B cells and
DCs promote alterations in the B cell compartment of MRL.Faslpr
mice. B cells in spleens from B-Myd88/ mice showed less
proliferation (Figure S3C) and apoptosis (Figure S3D), suggest-
ing less activation-induced cell death. Additionally, the larger
follicular B cell population in B-Myd88/ mice could partly be
the result of impaired plasmablast differentiation, which normally
might deplete follicular B cells (Figures 2A and 2B). However,
such a process would not contribute to increased follicular
B cell numbers in DC-Myd88D mice, because impaired AFC
differentiation was not observed in these mice (Figures 2D and
2E). We hypothesized that in DC-Myd88D mice, DCs produce
greater amounts of BAFF, a B cell survival factor. Yet, BAFF
mRNA levels in DCs from DC-Myd88D mice were substantially
lower than those in DCs from control mice (Figure 3C), and
similar results were obtained for the related cytokine APRIL.
Further, Myd88 deletion in DCs did not affect proliferation or
survival of B cells in the spleen (data not shown).
Because DC-specificMyd88 deletion had no detectable effect
on peripheral B cell homeostasis, we asked whether B lympho-
poiesis is regulated by DC-intrinsic MyD88 signaling. Increases
in B cell progenitors in DC-Myd88D mice were evident starting
at Hardy fraction B+C (CD45R+CD43+CD19+) (Figures 3D and
3E) corresponding to late pro-B and early pre-B cells. This effect
was specific, as indicated by the fact that total bone marrow
cellularity was unaffected byMyd88 deletion in DCs (Figure 3F).
Hardy fraction B+C cells had a lower frequency of cell death in
the absence of MyD88 in DCs (Figure 3G). Because survival
and growth of fraction B+C cells is mediated by IL-7 (Hardy
et al., 2007), those findings suggested stronger IL-7R signaling
in DC-Myd88D mice. Importantly, IL-7R signaling is inhibited by
IFN-I. This inhibition is dependent on the transcriptional
repressor DAXX (Death domain-associated protein 6) (Gongora
et al., 2001). Indeed, Hardy fraction B+C cells from control
mice had a higher DAXX mRNA content than those from
DC-Myd88D mice (Figure 3H). To identify the main source of
IFN-I in the bone marrow, we performed qRT-PCR for Ifna tran-
scripts on various myeloid cell types. pDCs showed the highest
Ifna mRNA levels and Ifna transcription in pDCs was strongly
dependent on DC-MyD88 (Figure 3I). These data are consistent
with a model in which MyD88 signaling in bone marrow pDCs
leads to the production of IFN-a, which mediates DAXX-depen-
dent inhibition of IL-7-induced growth and survival of B cell
progenitor cells.
Full Activation of cDCs in Systemic Autoimmunity
Requires DC- and B Cell-Intrinsic MyD88 Signaling
We assessed whether Myd88 deletion in DCs affected their
number and activation state. The frequency (Figure 4A) but not
number (Figure 4B) of cDCs in the spleens of DC-Myd88D mice
Figure 3. MyD88 Signaling in DCs Impairs B
Cell Lymphopoiesis
(A and B) Numbers of B cells (CD19hiCD138) per
spleen in (A) control (n = 12) and B-Myd88/
(n = 12) or in (B) control (n = 29) and DC-Myd88D
(n = 16) mice.
(C) Gene expression of BAFF and APRIL in sorted
splenic cDCs from 15-week-old control (gray bars,
n = 5) and DC-Myd88D (white bars, n = 6) mice as
determined by qRT-PCR. Data represent normal-
ized expression values relative to 6-week-old
preautoimmune wild-type MRL.Faslpr mice.
(D) B cell lymphopoiesis in the bone marrow of
control (n = 6) and DC-Myd88D (n = 7) mice.
Shown are representative staining profiles of
Hardy fractions A–E. Cells were first gated on
CD11bTCRbCD49b. Values indicate per-
centage (mean) of parent gate.
(E and F) Number of (E) cells in Hardy fraction A–E
and (F) total bone marrow cells after ACK lysis in
the femur and tibia of both legs of control (n = 6)
and DC-Myd88D (n = 7) mice.
(G) Cell death in Hardy fraction B+C cells. Dying
cells were identified by staining with EMA. n = 6 for
control and n = 7 for DC-Myd88D mice.
(H) Gene expression of DAXX in sorted bone
marrow Hardy fraction A and B+C cells from 13- to
16-week-old control (gray bars, n = 5) and DC-
Myd88D (white bars, n = 5) mice as determined by
qRT-PCR. Data represent normalized expression
values relative to total bone marrow cells from
control mice.
(I) Expression of IFN-a genes, using pan-Ifna
primers, in sorted bone marrow macrophages,
pDCs, and neutrophils from 16-week-old control
(gray bars, n = 6) and DC-Myd88D (white bars,
n = 6) mice as determined by qRT-PCR. Data
represent normalized expression values relative to
total bone marrow cells from control mice.
Graphs show mean values with SEM. See also
Figure S3.
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altered (Figures 4A and 4B). cDCs from DC-Myd88D and control
mice expressed comparable amounts of the costimulatory
molecules CD40, CD80, and CD86 (Figure 4C). To assess cyto-
kine production, we performed qRT-PCR on freshly harvested,
unmanipulated splenic cDCs from 16-week-old diseased DC-
Myd88D and control mice, as well as those from preautoimmune
6-week-old wild-type MRL.Faslpr mice. mRNA amounts of p35Immunity 38, 528–54and p40—which encode the two subunits
of IL-12—as well as Il6 were lower in
cDCs from aged DC-Myd88D mice than
in cDCs from aged controls (Figure 4D).
Transcripts of p40 and Il6 in cDCs from
old DC-Myd88D mice were even fewer
than in those from young wild-type
MRL.Faslpr mice (both p = 0.024). In
contrast there was a slight increase in
Tgfb1 transcripts in cDCs from old DC-
Myd88D mice compared to those from
old controls. Thus, in spontaneous age-dependent lupus, competence to synthesize IL-12 or IL-6, which
are required for priming of Th1 or Th17 and Th22 cells, respec-
tively, is critically dependent on DC-intrinsic MyD88 signaling.
Interestingly, we found that MyD88 signaling in B cells also
controls DC activation in lupus. cDCs from B-Myd88/ mice
had lower surface expression of CD40 and CD86 than did
cDCs from controls (Figure 4E). Like cDCs from old DC-
Myd88Dmice, cDCs from aged B-Myd88/mice also contained0, March 21, 2013 ª2013 Elsevier Inc. 533
Figure 4. Inflammatory Cytokine Production by cDCs Is Regulated by DC- and B Cell-Intrinsic MyD88 Signaling
(A) Representative staining profiles of splenic cDCs (CD11chiMHCII+CD19) and pDCs (Siglec-H+BST2+) of control (n = 29) and DC-Myd88D (n = 16) mice. Values
indicate percentage of live splenocytes (mean).
(B) Numbers of cDCs and pDCs in the spleen of control and DC-Myd88D mice gated as in (A).
(C) Representative staining histograms of gated cDCs from control (n = 29) and DC-Myd88D (n = 16) mice. Values indicate themean of theMFI (mean fluorescence
intensity).
(D) Gene expression of Il1b, Il6, p35, p40, Tgfb1, and Il10 in sorted splenic cDCs from 16-week-old control (n = 5) and DC-Myd88D (n = 6) mice as determined by
qRT-PCR. Data represent normalized expression values relative to 6-week-old preautoimmune wild-type MRL.Faslpr mice.
(E) As in (C) but for control (n = 8) and B-Myd88/ (n = 10) mice.
(F) As in (D) but for control (n = 4) and B-Myd88/ (n = 4) mice. cDCs were isolated from BM chimeras 21 weeks after transplantation.
Bar graphs show mean values with SEM.
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Functions of MyD88 in B Cells and DCs in Lupusfewer p35, p40, and Il6 transcripts and more Tgfb1 transcripts
compared to cDCs from aged controls (Figure 4F). This result
implies a forward loop in which B cells activated through
MyD88 contribute to the environment in which cDCs become
activated by DC-intrinsic MyD88 signaling, consistent with the
notion of cDCs being activated by nucleic acid-containing ICs
(Marshak-Rothstein, 2006). Together, these results indicate
that both DC- and B cell-intrinsic MyD88 signaling are necessary534 Immunity 38, 528–540, March 21, 2013 ª2013 Elsevier Inc.to endow cDCs with optimal ability to prime a T helper cell
response.
T Cell Activation Depends on MyD88 in B Cells but Not
DCs whereas T Cell Accumulation Relies on MyD88 in
Both Cell Types
We next sought to clarify the contributions of MyD88 signals in
B cells or DCs to the spontaneous T cell response. The
Immunity
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MRL.Faslpr mice, owing largely to the accumulation of activated
T cells, was substantially reduced in both B-Myd88/ and DC-
Myd88D mice (Figures 5A and 5B). Accordingly, splenic T cell
numbers were lower in mice without MyD88 in B cells or DCs
(Figure 5C). In B-Myd88/ mice, the percentage of CD4+
T cells with an activated-memory phenotype (CD44+) was appre-
ciably lower (73.1%) than in controls (90.0%) (Figures 5D and
S4A). Ablation of Myd88 in DCs did not impair spontaneous
CD4+ T cell activation (Figures 5D and S4A), consistent with
the minor role of DCs in CD4+ T cell activation in MRL.Faslpr
mice (Teichmann et al., 2010). For comparison, we confirmed
the previously reported finding that CD4+ T cell activation is
strongly dependent on B cells in the MRL.Faslpr strain (Chan
and Shlomchik, 1998). In B cell-deficient Jh MRL.Faslpr mice,
38.8% of CD4+ T cells displayed an activated-memory pheno-
type compared to 86.6% in controls (Figures 5D and S4A). The
greater decrease in CD4+ T cells with an activated-memory
phenotype in B cell-deficient MRL.Faslpr compared to
B-Myd88/ mice indicates that there are MyD88-dependent
and -independent functions of B cells in activating CD4+
T cells. Overall, MyD88 signaling in B cells but not DCs promoted
CD4+ T cell activation in lupus.
MyD88 Signals in B Cells and DCs Promote Th1 and
T Extrafollicular Helper Cell Differentiation
To test whether MyD88 in B cells or DCs is important in control-
ling CD4+ T cell differentiation fate, we determined frequencies of
relevant CD4+ T cell subsets. In B-Myd88/ mice, a smaller
fraction of CD4+ T cells had a Treg cell phenotype than in
controls (Figures 5E and S4B). Interestingly, in B-Myd88D mice,
in which Myd88 deletion in B cells is incomplete, we found the
opposite, a slight increase in Treg cells among CD4+ T cells (Fig-
ure S4B). A notable difference between B-Myd88D and
B-Myd88/ mice is the lower disease activity in the latter.
Treg cells increase in number and frequency among CD4+
T cells over the disease course in MRL.Faslpr mice (Divekar
et al., 2011), suggesting that MyD88 signaling in B cells, by
driving inflammation, promotes peripherally induced Treg cell
formation. Yet, other effects of MyD88 in B cells evidently inhibit
Treg cell differentiation. In lupus-prone and nonautoimmune
mice, loss of DCs leads to a loss of Treg cells (Darrasse-Je`ze
et al., 2009; Teichmann et al., 2010). In contrast, in DC-
Myd88D mice, the frequency of Treg cells among CD4+ T cells
was higher than in controls (Figures 5E and S4B). This is consis-
tent with our finding that DCs from these mice produce lower
amounts of inflammatory cytokines and more TGF-b1, which
induces FoxP3 in CD4+ T cells (Figure 4D).
Recently, a new CD4+ T cell population, called T extrafollicular
helper (Tefh) cells, has been described that promotes B cell
responses at extrafollicular sites and which is prominent in
MRL.Faslpr mice (Odegard et al., 2008). Like follicular helper
T cells that reside in GCs, Tefh cells depend on Bcl6, secrete
IL-21, and downregulate P-selectin glycoprotein ligand 1
(PSGL-1). Unlike follicular B helper T cells, which express
CXCR5, Tefh cells express CXCR4, corresponding to their extra-
follicular localization. The frequency of CD4+ T cells with a Tefh
cell phenotype was decreased in both B-Myd88/ and DC-
Myd88D mice compared to their respective controls (Figures5G and S4C). Thus, in addition to initiating AFC differentiation
directly in B cells, B cell-intrinsic MyD88 signals also indirectly
enhances the AFC response by supporting Tefh cells. Further,
the finding that DC-intrinsic MyD88 signaling leads to more
Tefh cells provides a mechanistic explanation for how DC-
MyD88 promotes autoantibody production.
Finally, we evaluated effects of MyD88 expression in B cells
and DCs on T cell IFN-g production. In human SLE, peripheral
blood T cells produce excessive amounts of IFN-g (Harigai
et al., 2008). In MRL.Faslpr mice, deletion of Ifng or Ifngr1
protects from disease (Balomenos et al., 1998; Schwarting
et al., 1998). In B-Myd88/ and DC-Myd88D mice, the fraction
of CD4+ T cells that produced IFN-g upon phorbol myristate
acetate (PMA) and ionomycin stimulation was lower than in
controls (Figures 5F and S4D). The reduction in IFN-g+ cells
among CD4+ T cells in mice lacking MyD88 in B cells was small
(31.4% in B-Myd88/ mice versus 38.1% in controls). B cell-
deficient Jh MRL.Faslpr mice, however, showed a marked
decrease in CD4+ T cells that produce IFN-g (13.7% in Jh
MRL.Faslpr mice versus 42.2% in controls), probably the conse-
quence of substantially reduced CD4+ T cell activation in these
mice. Differentiation of CD8+ T cells into IFN-g+ effectors was
marginally dependent on MyD88 in DCs but not B cells (Figures
5F and S4D), supporting the notion that B cells are not involved
in priming CD8+ T cell responses in lupus. Notably, IFN-g
production in CD4+ and CD8+ T cells is driven by IL-12, whose
expression was decreased in DCs isolated from both
B-Myd88/ and DC-Myd88D mice (Figure 4D). Taken together,
MyD88 signals in B cells and DCs facilitated differentiation of
T cell types that promote autoantibody formation and
inflammation.
Lupus Nephritis Is Controlled by MyD88 in B Cells
but Not DCs
To establish the impact of tissue-specific Myd88 deletion on
clinical disease, we scored dermatitis in DC-Myd88D and
B-Myd88D mice and their littermate controls. Because
MRL.Faslpr females develop more severe dermatitis than do
males, we restricted our analysis to females. Dermatitis severity
in B-Myd88D mice was indistinguishable from controls (Fig-
ure 6A). However, because of the incomplete deletion of
Myd88 in B-Myd88D mice, we cannot rule out that B cell-
intrinsic MyD88 signaling promotes skin manifestations of
lupus. Irradiation blocks dermatitis and therefore we could
not study B-Myd88/ mice for this phenotype. Unlike in
B-Myd88D mice, dermatitis in DC-Myd88D mice was greatly
ameliorated compared to controls (Figure 6B). To evaluate
renal disease, we used semiquantitative pathological scoring
of severity of glomerular nephritis (GN) and interstitial nephritis
(IN). Strikingly, B-Myd88D mice had markedly reduced GN
(Figures 6C and 6E). For IN we observed a downtrend (Fig-
ure 6C), which did not quite reach significance (p = 0.08). For
a quantitative assessment of IN, we measured the area of all
interstitial infiltrates relative to the total kidney section area.
This demonstrated clearly that IN was reduced in B-Myd88D
mice compared to controls (Figures 6D and 6F). Hence, T cell
infiltrates in kidneys depend on B cell-expressed MyD88. In
contrast, deletion of Myd88 in DCs had no effect on GN or IN
(Figure 6G). Proteinuria, a functional measure, confirmed theImmunity 38, 528–540, March 21, 2013 ª2013 Elsevier Inc. 535
Figure 5. MyD88 Signals in B Cells and DCs
Promote Th1 and Tefh Cell Differentiation
(A–C) Weight of (A) spleens and (B) the two
largest axillary lymph nodes and (C) T cell numbers
(TCRb+CD19) per spleen of (top) control (n = 12) and
B-Myd88/ (n = 12) mice or (bottom) control (n = 34)
and DC-Myd88D (n = 22) mice.
(D) CD44 and CD62L staining profiles of gated CD4+
T cells to identify naive (CD44loCD62Lhi) and activated
memory (CD44hi) subpopulations. Contour plots show
representative examples of B-Myd88/ (top), Jh
MRL.Faslpr (middle), and DC-Myd88D (bottom) mice
with their respective controls. Values indicate
percentage of CD4+ T cells (mean).
(E) FoxP3 and CD25 staining profiles of gated CD4+
T cells to identify Treg cells. Contour plots show
representative examples of B-Myd88/ (top) and DC-
Myd88D (bottom) mice with their respective controls.
Values indicate percentage of CD4+ T cells (mean).
(F) Representative intracellular IFN-g staining histo-
grams of gated CD4+ (left) and CD8+ (right) T cells of
PMA plus ionomycin-stimulated splenocytes from
B-Myd88/ (top), Jh MRL.Faslpr (middle), and DC-
Myd88D (bottom) mice with their respective controls.
Values indicate percentage of CD4+ or CD8+ T cells
(mean).
(G) CD62L and PSGL-1 staining profiles of gated CD4+
T cells after exclusion of CD45R+ cells to identify Tefh
cells. Contour plots show representative examples of
B-Myd88/ (top) and DC-Myd88D (bottom) mice with
their respective controls. Values indicate percentage of
CD4+ T cells (mean).
(D–G) n = 12 for B-Myd88/ mice and n = 10–12 for
controls; n = 5–8 for Jh MRL.Faslpr mice and n = 5–6
for controls; nR 18 for DC-Myd88D mice and n R 25
for controls.
Bar graphs show mean values with SEM. See also
Figure S4.
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Figure 6. Deletion of Myd88 in B Cells but Not DCs Protects MRL.Faslpr Mice from Lupus Nephritis
(A and B) Dermatitis scores of (A) control and B-Myd88D mice or of (B) control and DC-Myd88D mice.
(C) Glomerular nephritis was scored from 0 to 6 and interstitial nephritis from 0 to 4. Shown are scores of control and B-Myd88D mice.
(D) The area of interstitial infiltrates expressed as a percentage of the total kidney section area is plotted for control (n = 24) and B-Myd88D (n = 17) mice.
(E) Representative images of H&E-stained kidneys sections (scale bars represent 100 mm) illustrating glomerular nephritis (arrows) in kidneys from control and
B-Myd88D mice.
(F) Representative low-magnification images of H&E-stained kidney sections (scale bars represent 2 mm) illustrating perivascular infiltrates in kidneys from
control and B-Myd88D mice.
(G) As in (C) but for control and DC-Myd88D mice.
(H and I) Proteinuria scores of (H) control and B-Myd88D mice or of (I) control and DC-Myd88D mice.
Bar graphs show mean values with SEM. Scatter plots display data of individual mice and median values.
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than did control mice (Figure 6H), whereas DC-Myd88D mice
showed no reduction (Figure 6I).
In conclusion, activation of B cells through MyD88 was essen-
tial for the development of lupus nephritis. Although deletion of
DCs ameliorates kidney inflammation, deletion of Myd88 in
DCs did not. This implies that signals that are not transduced
by MyD88 are sufficient to induce DC functions critical for
nephritis. Interestingly, skin pathogenesis has different require-
ments, being dependent on DCs (Teichmann et al., 2010) and
in particular MyD88 signaling in DCs.DISCUSSION
Our study provides detailed insight into how MyD88 signaling
in B cells and DCs contribute to lupus pathogenesis and
suggests a refined model of functional interactions (Figure S5,
see legend for details). We formally established that ANA
formation is entirely dependent on MyD88 in B cells. Deletion
of Myd88 selectively in B cells ameliorated nephritis whereas
DC-specific ablation of Myd88 did not. These findings empha-
size the importance of B cells with specificity for nucleic acids
or associated proteins in activating pathogenic T cells. The factImmunity 38, 528–540, March 21, 2013 ª2013 Elsevier Inc. 537
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unexpected, because we previously showed that DCs per se
are critical for nephritis development (Teichmann et al., 2010).
Notably, dermatitis severity was impaired in the absence of
MyD88 in DCs, revealing a pathogenetic mechanism distinct
from that of kidney disease.
The complete loss of ANAs in MRL.Faslpr mice globally defi-
cient for MyD88 (Nickerson et al., 2010) was fully recapitulated
in MRL.Faslpr mice lacking MyD88 specifically in B cells. DC-
expressed MyD88 had only minor effects on autoantibody
formation. In view of a recent study (Hou et al., 2011), which
investigated the cell type-specific role of MyD88 for different
vaccination protocols, these results were surprising. In that
work, the cell-specific requirements for MyD88 expression
varied depending on the type of antigen. Responses to OVA-
CpG were enhanced by MyD88 signaling in DCs but not in
B cells. Other responses depended on B cell-expressed
MyD88, but in all cases a role for MyD88 in other cell types
was implied because decreases in serum concentrations of
antigen-specific antibodies in globally MyD88-deficient mice
were more pronounced than those in mice selectively lacking
Myd88 in B cells. Our findings thus contrast with those obtained
from immunization of nonautoimmune mice and underscore the
extraordinary dependence of ANAs on B-MyD88 in lupus.
Notably, other possible modes of B cell activation, such as
BCR and CD40 coligation, did not compensate for the loss of
MyD88 in B cells. Consequently, activated autoreactive T cells
on their own lack the ability to break tolerance in B cells and
induce AFC differentiation. Interestingly, B-Myd88/ mice
also had a >98% reduction in RF AFC numbers, indicating
that RF B cells are almost exclusively driven by ICs containing
nucleic acids.
Remarkably, 99% of total splenic AFCs were generated as
a result of B cell-intrinsic MyD88 signaling. Because AFCs are
hardly detectable in the spleens of unmanipulated nonautoim-
mune mice, commensals and common mouse pathogens are
unlikely to be major stimuli for splenic AFC differentiation.
Thus, the great majority of splenic AFCs in MRL.Faslpr mice is
probably self-reactive.
Despite incomplete Myd88 deletion in B-Myd88D mice, GN
and IN were both considerably ameliorated compared to
controls. The development of GN is thought to depend on IC
deposition, although some GN is observed in MRL.Faslpr mice
lacking secreted Ig and thus ICs (Chan et al., 1999). Nonethe-
less, the reduction in autoantibodies in B-Myd88D mice might
result in less IC deposition and GN. However, establishment of
IN is not contingent on Ig (Chan et al., 1999), arguing that lower
autoantibody amounts do not explain attenuated renal interstitial
infiltrates in B-Myd88D mice. Because IN is strongly dependent
on CD4+ T cells (Jabs et al., 1992; Jevnikar et al., 1994), our
results imply that activation of those CD4+ T cells that are essen-
tial for renal pathology is controlled by MyD88 in B cells. The
simplest interpretation is that B cells activated via MyD88
present antigen to and activate nephrotoxic CD4+ T cells. That
antigen presentation by B cells can lead to activation of naive
CD4+ T cells in vivo has been directly documented (Rodrı´guez-
Pinto and Moreno, 2005). Spontaneous CD4+ T cell activation
was indeed impaired in B-Myd88/ mice, although to a lesser
extent than in B cell-deficient Jh MRL.Faslpr mice, suggesting538 Immunity 38, 528–540, March 21, 2013 ª2013 Elsevier Inc.MyD88-dependent and -independent antigen-presenting func-
tions of B cells. Presumably, CD4+ T cells that are activated in
a B-MyD88-dependent manner recognize peptides from
nucleic acid-associated proteins. We therefore hypothesize
that CD4+ T cells with these specificities can cause or at least
indirectly promote tissue inflammation and damage. Defining
the precise specificities of disease-relevant T cells will require
the generation of T cell receptor transgenic mice for genuine
lupus autoantigens. Interestingly, B cell-specific deficiency for
IL-6 attenuated experimental autoimmune encephalomyelitis,
which was associated with an impaired Th17 cell response
(Barr et al., 2012). A further explanation for reduced IN in
B-Myd88/ mice could thus be a lack of B cell-derived inflam-
matory cytokines.
We tested whether the ability of splenic cDCs to produce cyto-
kines that are important for priming of T helper cell responses
depends on MyD88 in DCs, B cells, or both. As expected from
immunization studies (Joffre et al., 2009), MyD88 deficiency in
cDCs led to substantial reductions in p35, p40, and Il6 mRNA
amounts. Stimulation of the TLR-MyD88 axis in cDCs might be
facilitated by endocytosis of nucleic acid containing ICs
mediated by Fcg receptors, or alternatively by uptake of nucleic
acids bound to HMGB1 or LL37. Remarkably, decreases in
inflammatory cytokine transcripts in cDCs in B-Myd88/ mice
were comparable to those in DC-Myd88D mice. The strong
reliance of inflammatory cytokine production by cDCs on
MyD88 in B cells suggests that it is mainly ICs that drive full
cDC activation in lupus. Thus, our experiments provide evidence
for the concept of DC activation by nucleic acid-containing ICs
in vivo, a mechanism that has been shown only in vitro so far
(Marshak-Rothstein, 2006).
DC-expressed MyD88 regulated several aspects of B cell
biology: B cell lymphopoiesis, B cell positioning in the spleen,
IgG isotype subclass distribution, and (to a lesser degree) IgG
autoantibody production. MyD88 signaling in DCs promoted
B cell lymphopenia by impeding B cell lymphopoiesis. In B cell
progenitors, IFN-I induces DAXX, a transcription factor that
represses IL-7-dependent growth and survival (Gongora et al.,
2001). Our findings link IFN-I production by bone marrow
pDCs, resulting from cell-intrinsic MyD88 signaling, to DAXX-
dependent suppression of B lymphopoiesis in lupus. These
data are consistent with the observation that a strong IFN-I
signature in SLE patients is associated with more severe lym-
phopenia (Kirou et al., 2005), considered a risk factor for major
infections (Ng et al., 2006). Numerous in vitro studies have
demonstrated the ability of human pDCs to secrete IFN-I in
response to ICs containing TLR ligands (Ro¨nnblom et al.,
2011). However, in vivo data on TLR-dependent IFN-I production
by pDCs and its consequences in lupus have been missing
so far.
Interestingly, deletion of MyD88 in DCs led to the preservation
of B cell follicles and the development of GC-like structures in the
spleens of MRL.Faslpr mice, both of which are typically effaced
as these lupus-prone mice age. Infection with lymphocytic
choriomeningitis virus disrupts normal splenic architecture
subsequent to transient suppression of homeostatic chemo-
kines by IFN-g (Mueller et al., 2007). IFN-g hyperproduction is
found in both MRL.Faslpr mice and SLE patients (Harigai et al.,
2008; Teichmann et al., 2010). Notably, DC-Myd88Dmice harbor
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reduced IFN-g induction by MyD88-deficient DCs could cause
the preserved splenic architecture. The relationship between
DC-intrinsic MyD88 signaling, IFN-g, and spleen architecture
and function warrants further investigation in both mice and
humans.
We have previously demonstrated that DCs (Teichmann et al.,
2010) have nonredundant roles in dermatitis and nephritis path-
ogenesis. Unexpectedly, ablation of Myd88 in DCs attenuated
dermatitis but not nephritis, revealing separate pathogenetic
mechanisms. Unlike the kidneys, which are essentially sterile
organs, the skin is physiologically colonized by a microflora
and frequently exposed to pathogens. It is therefore possible
that skin DC subsets partly differ in function compared to those
in the kidneys. Alternatively, MyD88-dependent microbial
sensing might contribute to dermatitis in MRL.Faslpr mice,
although antibiotic treatment with cotrimoxazole or enrofloxacin
does not prevent its development (data not shown). Generally,
how DCs cause tissue damage is poorly understood and this
question merits more study.
In summary, we have delineated the unique immunopatholog-
ical effects of B cells and DCs that are directly activated by
nucleic acid recognition through the TLR-MyD88 pathway.
Based on these, we propose a hierarchy of events (Figure S5).
Understanding the means by which discrete cell populations in
complex multicellular networks become activated and the
functional consequences of different modes of activation will
probably enable the design of novel drugs for autoimmune
disorders, for example by targeting DCs or DC subsets.
EXPERIMENTAL PROCEDURES
Mice
Myd88fl/+ C57BL/6 (Kleinridders et al., 2009) and CD11c-Cre BAC transgenic
C57BL/6 (Caton et al., 2007) mice were backcrossed to MRL-MpJ-Faslpr/J
mice (Jackson Laboratory) 10 and 17 times, respectively. CD19-Cre C57BL/
6 (Rickert et al., 1997) mice were crossed ten times to MRL-MpJ-Faslpr/2J
and then five times to MRL-MpJ-Faslpr/J mice. Experimental mice were
generated by interbreeding CD11c-Cre Myd88fl/fl or CD19-Cre Myd88fl/fl
with Myd88fl/fl MRL.Faslpr mice. Littermates without a Cre allele were used
as controls. For mixed BM chimeras, 6- to 7-week-old B cell-deficient Jh
(Igh-Jtm1Dhu) MRL.Faslpr mice (Chan and Shlomchik, 1998) were irradiated
with 800 cGy and injected intravenously with 8 3 106 Jh MRL.Faslpr together
with 23 106Myd88/MRL.Faslpr (Nickerson et al., 2010) bone marrow cells.
Controls were generated in the same experiments using 2 3 106 Myd88+/+
instead of Myd88/ MRL.Faslpr bone marrow cells. Cre-loxP mice were
analyzed at 16 weeks of age and BM chimeras 21 weeks after transplantation,
unless otherwise stated. All animals were maintained under specific-path-
ogen-free conditions and handled according to protocols approved by the
Yale Institutional Animal Care and Use Committee.
Flow Cytometry
Surface staining was performed in ice-cold PBS with 3% calf serum in the
presence of FcR blocking Ab 2.4G2. Ab clones used for FACS can be found
in the Supplemental Information. Intracellular staining was performed with
the BD Cytofix/Cytoperm and Perm/Wash buffers or, for intracellular FoxP3
staining, the eBioscience FoxP3 staining buffer set. For intracellular IFN-g
staining, 4 3 106 splenocytes were cultured for 4 hr at 37C in 24-well plates
in 2 ml culture medium containing ionomycin (750 ng/ml) and PMA
(20 ng/ml). For the last 2 hr, brefeldin A (10 mg/ml) was added to the cultures.
Live and dead cells were distinguished with ethidium monoazide (EMA), and
gating strategies were used for doublet discrimination. Apoptotic cells were
identified by staining for active caspases with FITC-VAD-FMK (SM Biochem-icals). Cells were analyzed on a LSRII instrument (BD). For purification of
populations, cells were sorted on a FACSAria II (BD).
qRT-PCR
To quantify deletion efficacy of Myd88, genomic DNA was extracted from
FACS-purified cells and used as template for qRT-PCR. The amount of
Myd88 in each sample was normalized to the unaffected gene Il10. To
measure gene transcript abundance of APRIL, BAFF, DAXX, pan-Ifna, Il1b,
Il6, Il10, p35, p40, and Tgfb1, mRNA was isolated from FACS-purified cells
with the QIAGEN RNeasy Plus Mini Kit and reverse transcribed with the Bio-
Rad iScript cDNA Synthesis Kit. Gapdh was used as a housekeeping gene.
Primer sequences are listed in the Supplemental Information. qRT-PCR was
performed with the Agilent Brilliant II SYBR Green QPCR kit on a Stratagene
Mx3000P instrument.
ELISpots
To detect AFCs that produce k light chain antibodies, IgG1, IgG2a, or IgM
96-well Immulon 4 HBX plates were coated overnight at 4C with 5 mg/ml
polyclonal goat-anti mouse k (Southern Biotech; 1050-01). Nonspecific
binding was blocked with 1% bovine serum albumin in PBS and samples
were incubated at 37C. Alkaline phosphatase-conjugated secondary anti-
bodies (Southern Biotech; to k [1050-04], IgG1 [1070-04], IgG2a [1080-04],
or IgM [1020-04]) were detected with bromo-4-chloro-3-indolyl phosphate
substrate (Southern Biotech).
For anti-IgG1 and anti-IgG2a RF-producing AFCs, plates were coated
with 5 mg/ml C18 (anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) IgG1 l) and 23.3
(anti-NP IgG2a l), respectively. Biotinylated anti-k (187.1) was used as sec-
ondary antibody, followed by alkaline phosphatase-conjugated streptavidin.
ELISA and Luminex
Serum anti-nucleosome IgG, IgG1, and IgG2a concentrations were deter-
mined by ELISA as previously described (Nickerson et al., 2010). The nucle-
some-specific antibody clone PL2-3 was used as standard. Serum Ig isotype
concentrations were measured by Luminex assay (Millipore) according to the
manufacturer’s protocol.
ANAs
HEp-2 immunofluorescence assays (Antibodies, Inc.) were performed as
previously described (Christensen et al., 2005) with serum diluted at 1:100.
Images were captured on a Nikon Eclipse Ti-U microscope.
Evaluation of Clinical Disease
Dermatitis, nephritis, and proteinuria were scored as described previously
(Teichmann et al., 2010). Area of interstitial infiltrates relative to the total kidney
section area was calculated with ImageJ software.
Statistical Analysis
Statistics were calculated by two-tailed Mann-Whitney U test with p values
indicated throughout as *p < 0.05, **p < 0.01, ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2012.11.017.
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